Kaifang Ma Selected Research

Retinaldehyde (Retinal)

1/2020	The Genotype-Phenotype Association of Von Hipple Lindau Disease Based on Mutation Locations: A Retrospective Study of 577 Cases in a Chinese Population.
1/2019	Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaifang Ma Research Topics

Disease

9	Neoplasms (Cancer) 11/2023 - 01/2019
9	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 01/2019
4	Neoplasm Metastasis (Metastasis) 06/2023 - 03/2021
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 11/2023 - 01/2019
2	Carcinogenesis 01/2022 - 01/2022
2	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2020
2	Hemangioblastoma 01/2020 - 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	COVID-19 01/2021
1	Pheochromocytoma 01/2020
1	Pancreatic Cyst 01/2020
1	Cysts 01/2019

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
3	Long Noncoding RNAIBA 06/2023 - 03/2021
3	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 03/2021
3	N-methyladenosineIBA 01/2022 - 03/2021
2	Messenger RNA (mRNA)IBA 11/2023 - 01/2022
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	LuciferasesIBA 01/2021
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	6-methyladenineIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019

Therapy/Procedure

1	Vasectomy (Vas Occlusion) 12/2021
1	Nephrectomy 05/2019
1	Therapeutics 01/2019
1	Immunotherapy 01/2019